These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 37239101)
1. Successful Treatment of a Rare Cholesterol Homeostasis Disorder Due to Brlek P; Bulić L; Glavaš Weinberger D; Bošnjak J; Pavlović T; Tomić S; Krivdić Dupan Z; Borić I; Primorac D Biomedicines; 2023 May; 11(5):. PubMed ID: 37239101 [TBL] [Abstract][Full Text] [Related]
2. Differing clinical features between Japanese siblings with cerebrotendinous xanthomatosis with a novel compound heterozygous CYP27A1 mutation: a case report. Koyama S; Okabe Y; Suzuki Y; Igari R; Sato H; Iseki C; Tanji K; Suzuki K; Ohta Y BMC Neurol; 2022 May; 22(1):193. PubMed ID: 35614401 [TBL] [Abstract][Full Text] [Related]
3. Apparent underdiagnosis of Cerebrotendinous Xanthomatosis revealed by analysis of ~60,000 human exomes. Appadurai V; DeBarber A; Chiang PW; Patel SB; Steiner RD; Tyler C; Bonnen PE Mol Genet Metab; 2015 Dec; 116(4):298-304. PubMed ID: 26643207 [TBL] [Abstract][Full Text] [Related]
4. Spinal cerebrotendinous xanthomatosis: A case report and literature review. Atallah I; Millán DS; Benoît W; Campos-Xavier B; Superti-Furga A; Tran C Mol Genet Metab Rep; 2021 Mar; 26():100719. PubMed ID: 33659184 [TBL] [Abstract][Full Text] [Related]
5. A case of Cerebrotendinous Xanthomatosis with spinal cord involvement and without tendon xanthomas: identification of a new mutation of the CYP27A1 gene. Gelzo M; Di Taranto MD; Bisecco A; D'Amico A; Capuano R; Giacobbe C; Caputo M; Cirillo M; Tedeschi G; Fortunato G; Corso G Acta Neurol Belg; 2021 Apr; 121(2):561-566. PubMed ID: 31875301 [TBL] [Abstract][Full Text] [Related]
6. A case of cerebrotendinous xanthomatosis with brain and spinal involvement without tendon xanthomas: Identification of a novel mutation of the CYP27A1 gene. Stenos C; Kalafatakis K; Constantoulakis P; Zekiou K; Margoni A; Kardara P; Terentiou A; Stouraitis G; Nikolaou G J Clin Lipidol; 2022; 16(3):281-285. PubMed ID: 35428606 [TBL] [Abstract][Full Text] [Related]
7. Clinical report: A patient with a late diagnosis of cerebrotendinous xanthomatosis and a response to treatment. Alhariri A; Hamilton K; Oza V; Cordoro K; Sobreira NL; Malloy M; Slavotinek A Am J Med Genet A; 2017 Aug; 173(8):2275-2279. PubMed ID: 28590052 [TBL] [Abstract][Full Text] [Related]
8. [Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects]. Lionnet C; Carra C; Ayrignac X; Levade T; Gayraud D; Castelnovo G; Besson G; Androdias G; Vukusic S; Confavreux C; Zaenker C; De Seze J; Collongues N; Blanc F; Tranchant C; Wallon D; Hannequin D; Gerdelat-Mas A; Brassat D; Clanet M; Zephir H; Outteryck O; Vermersch P; Labauge P Rev Neurol (Paris); 2014; 170(6-7):445-53. PubMed ID: 24746394 [TBL] [Abstract][Full Text] [Related]
9. Chinese patient with cerebrotendinous xanthomatosis confirmed by genetic testing: A case report and literature review. Cao LX; Yang M; Liu Y; Long WY; Zhao GH World J Clin Cases; 2020 Nov; 8(21):5446-5456. PubMed ID: 33269283 [TBL] [Abstract][Full Text] [Related]
10. Prospective cholestanol screening of cerebrotendinous xanthomatosis among patients with juvenile-onset unexplained bilateral cataracts. Fernández-Eulate G; Martin GC; Dureau P; Speeg-Spatz C; Brassier A; Gillard P; Bremond-Gignac D; Thouvenin D; Pagan C; Lamari F; Nadjar Y Orphanet J Rare Dis; 2022 Dec; 17(1):434. PubMed ID: 36514115 [TBL] [Abstract][Full Text] [Related]
11. Cerebrotendinous Xanthomatosis: diversity of presentation and refining treatment with chenodeoxycholic acid. Islam M; Hoggard N; Hadjivassiliou M Cerebellum Ataxias; 2021 Jan; 8(1):5. PubMed ID: 33509302 [TBL] [Abstract][Full Text] [Related]
12. Late-onset Cerebrotendinous Xanthomatosis with a Novel Mutation in the CYP27A1 Gene. Sasamura A; Akazawa S; Haraguchi A; Horie I; Ando T; Abiru N; Takei H; Nittono H; Une M; Kurosawa T; Murai T; Naruse H; Nakayama T; Kotani K; Remaley AT; Kawakami A Intern Med; 2018 Jun; 57(11):1611-1616. PubMed ID: 29434128 [TBL] [Abstract][Full Text] [Related]
13. A Preventable Ataxia: Cerebrotendinous Xanthomatosis. Shaji B; Srikumar B; Ramachandran D Ann Indian Acad Neurol; 2019; 22(4):493-496. PubMed ID: 31736580 [TBL] [Abstract][Full Text] [Related]
14. Case report: Cerebrotendinous xanthomatosis with a novel mutation in the Chun MY; Heo NJ; Seo SW; Jang H; Suh YL; Jang JH; Kim YE; Kim EJ; Moon SY; Jung NY; Lee SM; Kim HJ Front Neurol; 2023; 14():1131888. PubMed ID: 36959818 [TBL] [Abstract][Full Text] [Related]
15. Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments. Koyama S; Sekijima Y; Ogura M; Hori M; Matsuki K; Miida T; Harada-Shiba M J Atheroscler Thromb; 2021 Sep; 28(9):905-925. PubMed ID: 33967188 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis. Mignarri A; Magni A; Del Puppo M; Gallus GN; Björkhem I; Federico A; Dotti MT J Inherit Metab Dis; 2016 Jan; 39(1):75-83. PubMed ID: 26153518 [TBL] [Abstract][Full Text] [Related]
17. Pathophysiology and Treatment of Lipid Abnormalities in Cerebrotendinous Xanthomatosis: An Integrative Review. Ribeiro RM; Vasconcelos SC; Lima PLGSB; Coelho EF; Oliveira AMN; Gomes EABM; Mota LA; Radtke LS; Carvalho MDS; Araújo DABS; Pinheiro MSN; Gama VCV; Júnior RMM; Braga Neto P; Nóbrega PR Brain Sci; 2023 Jun; 13(7):. PubMed ID: 37508912 [TBL] [Abstract][Full Text] [Related]
18. Progressive ataxia of cerebrotendinous xanthomatosis with a rare c.255+1G>T splice site mutation: A case report. Chang YY; Yu CQ; Zhu L World J Clin Cases; 2022 Oct; 10(29):10681-10688. PubMed ID: 36312475 [TBL] [Abstract][Full Text] [Related]